Novartis acquires Japanese generics business in €400m deal

12-11-2019

Rory O'Neill

Novartis acquires Japanese generics business in €400m deal

II.studio / Shutterstock.com

Novartis has agreed to buy the Japanese business of South African generics manufacturer Aspen Pharmacare for a potential €400 million ($440.7 million).


Novartis, Sandoz, Aspen, Richard Saynor, Xylocaine, Imuran, mergers and acquisitions

LSIPR